Top Tweets for #COMY22

about 4 years ago

🎥Weekend Rewatch During the #COMy22, the Multiple Myeloma Hub was pleased to speak to @H_Einsele, Hermann Einsele, Julius-Maximilians-Universität Würzburg. We asked, How do you manage bridging therapies prior to CAR T cells in multiple myeloma? https://t.co/9CklcTJHkw #MMsm

0

2

0

about 4 years ago

🎥 Weekend watch! During #COMy22, the MM Hub was pleased to speak to María-Victoria Mateos, University Hospital of Salamanca. We asked, What are the current and future strategies for maintenance therapy after autologous transplant? https://t.co/0eIrqHXtW9

0

8

0

over 4 years ago

At #COMy22, Sonja Zweegman discussed how ultra-frail patients with multiple #myeloma are at higher risk of treatment discontinuation and adverse outcomes and how crucial it is to identify them in the clinic accurately. Read a summary here👇 #mmsm #gerionc https://t.co/DBYkB32CpN

MM_Hub's tweet photo. At #COMy22, Sonja Zweegman discussed how ultra-frail patients with multiple #myeloma are at higher risk of treatment discontinuation and adverse outcomes and how crucial it is to identify them in the clinic accurately.
Read a summary here👇
#mmsm #gerionc
https://t.co/DBYkB32CpN https://t.co/FR03Agjy1a

0

6

5

0

over 4 years ago

🎥 During the #COMy22 , the MM Hub was pleased to speak to @rajshekharucms, Herbert Irving Comprehensive Cancer Center. We asked, What are the initial results of antibody–drug conjugate (ADC)-based combinations❓ Watch the video here 👇 https://t.co/d6yKPUdAGY

0

5

2

0

over 4 years ago

🎥 During the #COMy22, the MM Hub was pleased to speak to @IreneGhobrial, @DanaFarber. We asked, What have we learnt about monoclonal gammopathy of undetermined significance (MGUS) prevalence and clinical implications❓ #myeloma #mmsm https://t.co/5SgDHBJ5RW

0

7

5

0

over 4 years ago

🎥 During the #COMy22, the Multiple Myeloma Hub was pleased to speak to @H_Einsele, Julius-Maximilians-Universität Würzburg. We asked, How do you manage bridging therapies prior to CAR T cells in multiple myeloma❓ https://t.co/9CklcTJ9uY

0

2

0

over 4 years ago

🎥 During #COMy22, the MM Hub was pleased to speak to María-Victoria Mateos, University Hospital of Salamanca. We asked, What are the current and future strategies for maintenance therapy after autologous transplant❓ https://t.co/0eIrqHXtW9

0

5

1

0

over 4 years ago

Mohamad Mohty (@Mohty_EBMT) discusses the importance of induction therapy prior to autologous stem cell transplantation: 👉https://t.co/8UoawQ7mrN👈 @COMyCongress #COMy22 #MMsm #HemOnc #Myeloma #BMTsm

0

11

4

1

0

over 4 years ago

Meral Beksac (@mbeksac56) discusses the value of MRD as a prognostic tool in myeloma. Watch her interview here: 🎥: https://t.co/94sD3dWSK3 @COMyCongress #COMy22 #MMsm #Myeloma #mmMRD

0

14

4

1

0

over 4 years ago

Alberto Romagnoni (@OwkinScience) discusses the role of artificial intelligence for precision medicine in multiple myeloma. Watch here: https://t.co/fsPdPNBBMH @COMyCongress #COMy22 #HemOnc #MMsm

0

2

3

0

over 4 years ago

Bruno Paiva (@BrunoPaiva_UNAV) discusses the benefit of using MRD to guide treatment in myeloma: 🎥: https://t.co/1Mw5tsDtTx @COMyCongress #COMy22 #MMsm #HemOnc #mmMRD

0

3

0

over 4 years ago

Sagar Lonial (@SagarLonialMD) discusses recent updates on CELMoDs in multiple myeloma. Watch now: 🎥: https://t.co/hcee0saXNW @COMyCongress #COMy22 #MMsm #HemOnc #ImmunoOnc #Myeloma

0

4

3

1

0

over 4 years ago

Kwee Yong (@ucl) discusses recent advances in newly diagnosed myeloma and the importance of patient perspectives: 🎥: https://t.co/YT4fyId2Ff @COMyCongress #COMy22 #HemOnc #MMsm #Myeloma #ImmunoOnc

0

3

1

0

over 4 years ago

Kenneth Anderson (@DanaFarber) shares some interesting insights into the future of myeloma treatment, as well as the possibility of cure. Watch his wonderful interview here: 🎥: https://t.co/igXSZaQ9jr @COMyCongress #COMy22 #MMsm #Myeloma #HemOnc #ImmunoOnc

0

13

7

0

over 4 years ago

Karthik Ramasamy (@OUHospitals) discusses the use of clonoSEQ as a tool to measure MRD negativity. 🎥: https://t.co/OYOxvCWO0h @COMyCongress #COMy22 #MMsm #mmMRD #Myeloma #HemOnc

0

6

3

1

0

over 4 years ago

At #COMy22, there were so many wonderful presentations and discussions covering the latest in the field of myeloma. If you missed out - don't worry! We have everything you need here: 👉https://t.co/TdejcFHaAx👈 @COMyCongress #MMsm #Myeloma #HemOnc

VJHemOnc's tweet photo. At #COMy22, there were so many wonderful presentations and discussions covering the latest in the field of myeloma. If you missed out - don't worry!

We have everything you need here:

👉https://t.co/TdejcFHaAx👈

@COMyCongress #MMsm #Myeloma #HemOnc https://t.co/N0WMJnIuoq

0

4

2

1

0

over 4 years ago

Giampaolo Merlini, MD, shares some insights into recent advances in AL amyloidosis, including the importance of early diagnosis: 👉https://t.co/u1jVehNqqh👈 @COMyCongress #COMy22 #Amyloidosis #MMsm #HemOnc

0

2

1

0

Yelak Biru @NorthTxMSG

over 4 years ago

"I go to @COMyCongress #COMy22 to get up-to-date information" is one of the most common comments I heard recently from MANY patient organizations in Europe. @Mohty_EBMT thanks for your leadership, making it accessible for Pts/Advocates! #mmsm

1

13

5

0